Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
- Status
- COMPLETED
- Phase
- PHASE3
BO-112 With Pembrolizumab in Unresectable Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)
- Status
- TERMINATED
- Phase
- PHASE1
Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)
- Status
- WITHDRAWN
- Phase
- PHASE2
Islatravir and Methadone Pharmacokinetics (MK-8591-029)
- Status
- COMPLETED
- Phase
- PHASE1
Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]
- Status
- COMPLETED
- Phase
- PHASE2
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
HepATocellular Cancer Hcv Therapy Study
- Status
- WITHDRAWN
- Phase
- PHASE3
Sugammadex To IMprove Bowel Function
- Status
- COMPLETED
- Phase
- PHASE4
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
- Status
- TERMINATED
- Phase
- N/A
Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)
- Status
- COMPLETED
- Phase
- PHASE1
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Metformin on Immuno-virologic Parameters in HIV
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3